ALTEN after the H1 print, with Capgemini as the foil


ALTEN ALTEN had a good week before the filings even hit the tape. The company said H1 revenue reached EUR 2,109.2 million, up 1.2% reported and 1.6% organically, with second-quarter organic growth of 3.3% helped by defense, aerospace, rail, and energy, while automotive kept dragging. Then the stock closed at EUR 79.80 on July 29, up 19.46% from the prior session’s EUR 66.80. That is the kind of move that changes the tone around any insider sale, because a stock that has just repriced higher invites both celebration and distribution.
Capgemini is the cleaner comparison here because it sits in the same broad European services universe, but with a different mix and a much larger, more diversified footprint. ALTEN is the more concentrated engineering and technology consultancy, with more direct exposure to industrial and defense-linked demand. Capgemini is the bigger, broader reference point for how the market prices European services resilience. If you want to know whether ALTEN’s July 30 sales matter, you have to ask whether management is selling into a one-off rerating or into a business that has genuinely turned the corner.
The first filing came from Pascal Amore, who sold about EUR 173,800 of stock in euro-normalised filing value. The second came from Pascal Agin, who sold about EUR 76,000. Both were filed on July 30, both were marked as sales, and both were flagged as part of a cluster in the AMF disclosures. The combined value is about EUR 249,800. That is the number that matters first, because it tells you the scale of the action before you start reading motive into it.
Scale matters because the company does not. ALTEN’s market value in the dossier is EUR 2.56 billion, so the larger sale is a tiny fraction of the equity base. InsiderTrades data puts the larger transaction at 0.007620432651159919% of market cap and the smaller one at 0.00333229506034611%. Those are not balance-sheet moves. They are personal portfolio decisions, and the market should treat them that way before it does anything more dramatic.
Still, the roles are not random. Amore is listed as an executive director in charge of ALTEN in Asia, and Agin is an executive director for project steering and performance. This is not a lone back-office filing from someone with no operational proximity. It is two executives, on the same day, after a strong earnings reaction. That combination is why the cluster matters more than either ticket alone.
ALTEN’s first-half numbers gave the stock a reason to move. Revenue of EUR 2,109.2 million, 1.2% reported growth, and 1.6% organic growth are not the sort of figures that usually produce a 19.46% one-day jump on their own. The market was reacting to the second quarter, where organic growth reached 3.3%, and to the fact that the company raised full-year 2026 organic growth guidance to 1.4% to 1.8% from 0% to minus 0.5%. It also flagged operating profitability near 9%.
That is the real backdrop for the sales. A stock that had been priced for little or no growth suddenly got a better guide, a better second quarter, and a better tone around the end markets that matter most to ALTEN. Defense, aerospace, rail, and energy were the bright spots. Automotive was still down double digits. So the market was not buying a clean cyclical recovery. It was buying a selective one, and that distinction matters when you compare ALTEN with Capgemini.
Capgemini does not have the same end-market concentration, which can be a blessing when one industrial pocket weakens and a curse when the market wants sharper operating leverage. ALTEN’s exposure to defense and aerospace has helped it look more resilient than a generic services name in this phase. But the same concentration can make the stock more sensitive to any hint that the good news is already in the price. That is the tension the July 30 sales sit inside.
InsiderTrades data scores the larger sale at 4.1, and the score is being pushed by three things that are visible in the dossier, not by some mystical reading of the filing. The role is heavily weighted because it comes from a chief executive level insider. The sale sits inside a cluster, with multiple insiders trading the name within a month. And the filing value is small relative to the company. The score is a screen, not a verdict, but it does help separate a routine disposal from a more interesting pattern.
The cluster itself is not a one-off. The dossier shows five recent declarations, all sales, stretching back to May 19, with Pascal Amore appearing on June 9 and July 13 before the July 30 filing, and Stéphane Ougier also selling on May 19. That is a steady stream, not a single burst. You do not need to overread it to see the point. Management has been trimming into strength, and the July 30 pair extends that pattern rather than breaking it.
Against Capgemini, that is the sharper read. Capgemini may be the larger, more diversified peer, but it is not the one with a visible cluster of executive sales right after a sharp rerating and a guidance raise. ALTEN is the name where the insider tape and the price action are colliding in public. Capgemini is the benchmark. ALTEN is the one with the filing pattern.

The relevant historical cohort in the dossier is chief-executive buys at mid-cap names, with 2,392 observations. That bucket posted a 49.4% 90-day win rate, an average 90-day return of 1.85%, and an average 365-day return of 64.95%. Those are historical cohort numbers, not a forecast for ALTEN, and they are not even the same direction as this filing. I am using them because they tell you something about the broader behavior of executive-level insider activity in this size band, not because they promise anything about a sale after a rally.
The mismatch matters. This is a sell cluster, not a buy. The cohort is a useful reference point for how executive activity in mid-caps has behaved over time, but it does not rescue or condemn this specific trade. If anything, it reminds you to keep the filing in proportion. A sale after a 19.46% jump is not the same animal as a buy after a drawdown, and the historical bucket should not be forced to do work it was never built to do.
ALTEN’s own internal profile is middling rather than pristine. The dossier shows a fundamental score of 56, with a quality score of 42 and a value score of 69. That is not a disaster, and it is not a glowing screen either. It fits a company that has enough operational strength to raise guidance, but not enough to make the market forget the automotive drag or the unevenness in the end-market mix.
ALTEN’s execution story is narrower and easier to test than Capgemini’s. If defense, aerospace, rail, and energy keep carrying the quarter, the market will keep giving the company credit for being in the right pockets of demand. If automotive stays weak and the industrial cycle softens, the rerating can fade quickly. That is the trade-off in a business services name with real end-market exposure. The July 30 sales sit right on top of that trade-off.
Capgemini, by contrast, is the steadier comparison because its revenue base is broader and its client mix less tied to a few industrial verticals. That does not make it better. It makes it different. ALTEN can look faster when the right end markets are working, and more exposed when they are not. The market rewarded that speed after the H1 update. The insiders sold into that reward. You can call that prudent, opportunistic, or simply personal. You cannot call it invisible.
The share repurchase activity through late July adds another layer. The company was still supporting liquidity with buybacks while the stock was moving sharply higher. That can help stabilize trading, but it also means the market had multiple forces pushing on the shares at once, earnings, guidance, repurchases, and then insider sales. When several things happen in the same window, the cleanest mistake is to pretend one of them explains everything.
The comparison with Capgemini has limits. ALTEN is not a mini-Capgemini, and the market does not value it that way. Its engineering and technology consultancy model gives it more direct sensitivity to industrial capex, defense spending, and project timing. Capgemini’s broader IT and consulting mix gives it a different rhythm. So if you are trying to infer something about the whole European services sector from ALTEN’s July 30 sales, you will overreach fast.
The filing also does not tell you whether the executives were selling for tax, diversification, or simple housekeeping after a strong move. The AMF disclosures do not hand you motive. They hand you timing, role, direction, and size. That is enough to matter, and not enough to pretend certainty. The market has to do the rest.
InsiderTrades data keeps the signal modest for a reason. The larger sale scores 4.1, which is not a screaming number. The amount is small relative to market cap. The cluster is real, but it is a cluster of sales after a rally, not a panic exit. So the right conclusion is not that ALTEN is broken. It is that management has been using strength to trim, while the business itself has just given the market a better guide than it had before.
The next useful check is not another abstract sector call. It is whether ALTEN can keep the 3.3% second-quarter organic growth pace from looking like a one-quarter burst. If defense, aerospace, rail, and energy keep offsetting automotive, the market will keep treating the H1 update as something more durable than a relief rally. If not, the July 30 sales will start to look better timed in hindsight.
Capgemini remains the peer to watch because it gives you the broader read on how European services names are being priced. If the market keeps rewarding resilient execution there, ALTEN can stay in the conversation. If the peer group rolls over while ALTEN holds up, then the company-specific end-market mix will have done the heavy lifting. Either way, the insider cluster will sit in the background as a reminder that executives were willing to sell after the rerating, not before it.
For now, the facts are plain. ALTEN posted a better-than-feared H1, raised guidance, saw the stock jump, and then filed two executive sales on July 30. Capgemini gives you the comparison point, but not the answer. The answer will come from the next trading update, the next read on industrial demand, and whether the recent buyback support keeps meeting the market where it is.
This is not investment advice.
BASF is buying back €1bn of stock while chemicals stay sluggish. Here is what the latest company news, peers and insider...
Hermès is still trading off its July 29 half-year reset, with China soft and Western demand firm. No fresh insider trade...
Tikehau Capital’s co-founder bought EUR 355,883 on August 7 as European alternatives trade against steadier rates, bette...
Twist Bioscience has rallied 265% this year, but a six-insider selling cluster and Dennis Cho's August 5 sale complicate...
NIKE COO Alagirisamy Venkatesh sold 890 shares on August 5. The filing lands beside a wider August cluster and a weak co...
Circle’s CEO filed multiple August 7 sales after Q2, while USDC growth, rate sensitivity and peer moves frame the read.